desethyloxybutynin has been researched along with Bladder Disorder, Neurogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capelli, G; Di Stasi, SM; Giannantoni, A; Navarra, P; Porena, M; Stephen, RL; Storti, L | 1 |
| Hakonen, T; Lehtoranta, K; Lukkari-Lax, E; Tainio, H; Tammela, TL | 1 |
1 trial(s) available for desethyloxybutynin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
Topics: Administration, Intravesical; Adolescent; Adult; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 2002 |
1 other study(ies) available for desethyloxybutynin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin.
Topics: Administration, Intravesical; Adolescent; Adult; Cholinergic Antagonists; Diffusion; Electrochemistry; Female; Humans; Male; Mandelic Acids; Middle Aged; Urinary Bladder, Neurogenic; Urodynamics | 2001 |